FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

CUSIP: 33938JAB2

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Debt / NOTE 3.375% 5/0
Market price (% of par)
90.59%
Total 13F principal
$165,016,982
Principal change
-$30,763,018
Total reported market value
$150,165,234
Number of holders
28
Value change
-$27,393,729
Number of buys
9
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 as of Q1 2021

As of 31 Mar 2021, FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 was held by 28 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $165,016,982 in principal (par value) of the bond. The largest 10 bondholders included LAZARD ASSET MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, Birch Grove Capital LP, SILVERBACK ASSET MANAGEMENT LLC, Opti Capital Management, LP, ADVENT CAPITAL MANAGEMENT /DE/, TENOR CAPITAL MANAGEMENT Co., L.P., BNP PARIBAS ARBITRAGE, SA, and WELLS FARGO & COMPANY/MN. This page lists 28 institutional bondholders reporting positions for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.